AI Article Synopsis

  • Optimal placement of left ventricular (LV) leads during cardiac resynchronization therapy (CRT) can enhance patient outcomes, but can be affected by difficult venous anatomy.
  • This study aimed to evaluate the safety and effectiveness of percutaneous coronary venoplasty (PCV) during CRT implantation and compare medium-term results with patients who did not require PCV.
  • Out of 422 CRT recipients, 29 needed PCV, achieving a 72% success rate without complications, and showed no significant differences in long-term lead performance or survival compared to the control group, suggesting PCV is a beneficial technique for optimal LV lead positioning.

Article Abstract

Background: Optimal left ventricular (LV) lead placement improves response to cardiac resynchronization therapy (CRT) but can be hindered by unfavorable venous anatomy. Interventional procedures in the coronary veins have been described with promising short-term outcomes.

Objective: The purpose of this study was to establish the safety and efficacy of percutaneous coronary venoplasty (PCV) during CRT implantation and assess medium-term lead performances and clinical outcomes against matched controls not requiring PCV.

Methods: Each consecutive PCV case was matched according to age, gender, and bundle branch morphology to 2 controls from a large prospective registry of CRT recipients. Demographics, procedural success, lead performance, and response to CRT were tracked using a comprehensive electronic medical records system.

Results: Of 422 consecutive CRT recipients treated between 2012 to 2018, 29 patients (6.9%; mean age 65.7 ± 10.7 years; 7 female; 17 ischemic cardiomyopathy; 22 left bundle branch block) required PCV, which was successful in 21 cases (72%). Target veins measuring 1.1 ± 0.6 mm were dilated by noncompliant balloons with mean diameter 2.8 ± 0.5 mm. No complications occurred. Fluoroscopic and procedural durations were longer in the PCV group (P <.01) Over mean follow-up of 33.0 ± 25.0 months, no differences in lead performance, CRT response, or 2-year survival were observed compared to the control group.

Conclusion: PCV during CRT device implant is typically successful, safe and associated with long-term clinical outcomes comparable to patients who did not need PCV. This is an important technique to optimize LV lead placement and maximize CRT response.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hrthm.2019.12.012DOI Listing

Publication Analysis

Top Keywords

coronary venoplasty
8
cardiac resynchronization
8
resynchronization therapy
8
clinical outcomes
8
bundle branch
8
crt recipients
8
crt
5
venoplasty cardiac
4
therapy device
4
device implantations
4

Similar Publications

Background: Fibrosing mediastinitis (FM) is a rare yet fatal condition, caused by different triggers and frequently culminating in the obstruction of the pulmonary vasculature and airways, often leading to pulmonary hypertension and right heart failure. Percutaneous transluminal pulmonary venoplasty (PTPV) is an emerging treatment for pulmonary vein stenosis (PVS) caused by FM. Our previous study showed as high as 24% of in-stent restenosis (ISR) in FM.

View Article and Find Full Text PDF

Percutaneous balloon venoplasty for symptomatic lead-related venous stenosis.

Heart Rhythm

October 2024

Electrophysiology Section, Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address:

Article Synopsis
  • Lead-related venous stenosis (LRVS), often diagnosed incidentally, can cause symptoms like swelling and discomfort in patients with transvenous leads, although actual symptomatic cases are rarer.
  • A study at the Hospital of the University of Pennsylvania analyzed 18 patients with symptomatic LRVS who did not respond to anticoagulation and underwent balloon venoplasty, finding that a significant majority (72%) experienced complete symptom relief post-procedure.
  • The study concluded that while balloon venoplasty is generally safe and effective, timely intervention is crucial, especially as treatment becomes less effective when secondary lymphedema is present.
View Article and Find Full Text PDF

In May-Thurner syndrome (MTS), the left iliac vein is compressed by the right iliac artery, leading to restricted blood flow from the leg to the heart. MTS commonly manifests in young females; however, its occurrence in older adults necessitates verifying the possibility of malignancy. A 77-year-old female experienced leg swelling and discomfort for 1 week.

View Article and Find Full Text PDF

The endovenous embolization of insufficient abdominal/pelvic veins is the preferred method of treatment. Also, it seems to be crucial in the treatment of lower limb vein insufficiency, particularly in recurrent disease. This study aimed to evaluate of pelvic vein embolization safety and its impact on the short-term outcome in the sequential treatment of venous disease.

View Article and Find Full Text PDF

Pancreatic resection not infrequently requires portal vein (PV) repair or replacement. PV reconstruction often requires bypass grafting or patch venoplasty, and these grafts and patches require time to thaw or harvest. Mesenteric ischemia and congestion with associated bowel edema may result from prolonged venous occlusion during thawing, harvesting, and reconstructing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!